ALCOHOL LIVER DISEASE | Webcasts
Back Identification and Management of MetALD
04/09/2026
Live from the 2026 Liver Connect Conference, Luis Antonio Diaz Piga, MD, Zobair Younossi, MD, MPH, Scott D. Isaacs, MD, FACP, FACE, and Manal Abdelmalek, MD, MPH review the Identification and Management of MetALD. This session explores metabolic dysfunction–associated alcohol-related liver disease (MetALD), a newly defined subtype of steatotic liver disease that reflects the overlap between metabolic dysfunction and alcohol-related liver injury.
